IGEV Followed by Autologous Transplantation for Refractory or Relapsed Hodgkin Lymphoma
Status:
Unknown status
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The aim of study is to prove IGEV regimen followed by autologous stem cell transplantation as
salvage treatment in patients with refractory or relapsed Hodgkin lymphoma is effective.